Insulin Glargine: all 295 studies that test it
Page 1 of 3. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 DiabetesNot yet recruitingNCT07173712Phase 4
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced DiabetesEnrolling by invitationNCT07117240Phase 4
- iGlarLixi CGM Study in Chinese T2D Individuals After OADsRecruitingNCT06671587Phase 4
- RCT Glargine vs NPH for Treatment of DM in PregnancyRecruitingNCT06619301Phase 3
- Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different RegimensRecruitingNCT02587741Early Phase 1
- A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCompletedNCT06340854Phase 3Results posted
- Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource SettingsCompletedNCT05614089Phase 4Results posted
- Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal ImpairmentTerminatedNCT05552859Phase 4Results posted
- A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsCompletedNCT05462756Phase 3Results posted
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)CompletedNCT05413369Phase 3Results posted
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes MellitusCompletedNCT05114590Phase 4Results posted
- Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine DoseCompletedNCT04623086Phase 4Results posted
- Early Basal Insulin Administration in Adult Diabetic Ketoacidosis ManagementTerminatedNCT04567225Phase 4Results posted
- A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaCompletedNCT04153981Phase 4Results posted
- Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes PatientsCompletedNCT04075513Phase 4Results posted
- Remission Through Early Monitored Insulin Therapy - Duration MonthCompletedNCT03670641Phase 4Results posted
- A Study of Insulin Glargine (LY2963016) in Healthy Chinese ParticipantsCompletedNCT03555305Phase 1Results posted
- Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic AgentsTerminatedNCT03434119Phase 3Results posted
- Mylan Insulin Glargine StudyCompletedNCT03376789Phase 3Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusCompletedNCT03338023Phase 3Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes MellitusCompletedNCT03338010Phase 3Results posted
- Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)TerminatedNCT03260868Phase 4Results posted
- Early Glargine (Lantus) in DKA Management in Children With Type 1 DiabetesCompletedNCT03107208Phase 4Results posted
- Glargine U300 Hospital TrialCompletedNCT03013985Phase 4Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodCompletedNCT02787551Phase 3Results posted
- Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCompletedNCT02738151Phase 4Results posted
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT02735044Phase 3Results posted
- A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT02688933Phase 4Results posted
- Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02680457Phase 4Results posted
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 DiabetesCompletedNCT02455076Phase 4Results posted
- Glargine Versus NPH in Patients With Chronic Kidney DiseaseCompletedNCT02451917Phase 4Results posted
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedNCT02451137Phase 4Results posted
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT02408120Phase 4Results posted
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsCompletedNCT02320721Phase 3Results posted
- A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusCompletedNCT02302716Phase 3Results posted
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusCompletedNCT02229227Phase 3Results posted
- A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCompletedNCT02132637Phase 3Results posted
- The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)CompletedNCT02059187Phase 3Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)CompletedNCT02059174Phase 1Results posted
- A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)CompletedNCT02059161Phase 3Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT02058160Phase 3Results posted
- A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCompletedNCT02034513Phase 3Results posted
- A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesCompletedNCT02030600Phase 3Results posted
- Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosisCompletedNCT02006342Not applicableResults posted
- Linagliptin Inpatient TrialCompletedNCT02004366Phase 4Results posted
- Comparison of Insulin Therapy in Treating Post-Transplant DiabetesTerminatedNCT01963728Phase 4Results posted
- Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DMCompletedNCT01855243Not applicableResults posted
- A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01849289Phase 3Results posted
- Sitagliptin Therapy in Hospitalized Patients With Type 2 DiabetesCompletedNCT01845831Phase 4Results posted
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedNCT01794143Phase 3Results posted
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) PatientsCompletedNCT01792830Phase 3Results posted
- RISE Pediatric Medication StudyCompletedNCT01779375Phase 3Results posted
- RISE Adult Medication StudyCompletedNCT01779362Phase 3Results posted
- A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy ParticipantsCompletedNCT01688635Phase 1Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT01683266Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCompletedNCT01676220Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01658579Phase 2Results posted
- A Study of LY2963016 in Healthy ParticipantsCompletedNCT01634165Phase 1Results posted
- A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCompletedNCT01600950Phase 1Results posted
- A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose InsulinCompletedNCT01570751Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCompletedNCT01499095Phase 3Results posted
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01499082Phase 3Results posted
- Simplified Insulin Protocol Using Lantus in ElderlyCompletedNCT01480843Phase 4Results posted
- A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy ParticipantsCompletedNCT01476345Phase 1Results posted
- A Study in Adults With Type 2 DiabetesCompletedNCT01421459Phase 3Results posted
- A Study in Adults With Type 1 DiabetesCompletedNCT01421147Phase 3Results posted
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedNCT01378117Phase 4Results posted
- A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy SubjectsCompletedNCT01374178Phase 1Results posted
- Satisfaction of Treatment Among Elderly Patients With Insulin TherapyCompletedNCT01240200Phase 4Results posted
- Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusCompletedNCT01226043Phase 4Results posted
- Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the HospitalCompletedNCT01203774Phase 4Results posted
- Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced HyperglycemiaCompletedNCT01184014Phase 4Results posted
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
- Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular InsulinTerminatedNCT01136746Phase 3Results posted
- Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)CompletedNCT01135992Phase 3Results posted
- Diabetes in the Elderly: Prospective StudyCompletedNCT01131052Phase 4Results posted
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents FailureCompletedNCT01117350Phase 4Results posted
- Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin GlargineCompletedNCT01089569Not applicableResults posted
- A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
- Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
- Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3Results posted
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCompletedNCT00993473Phase 3Results posted
- Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00979628Phase 4Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
- Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT00911625Phase 4Results posted
- Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 DiabetesTerminatedNCT00869414Not applicableResults posted
- Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension TrialCompletedNCT00851903Phase 3Results posted
- Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive PatientsCompletedNCT00751114Phase 4Results posted
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-WeeksTerminatedNCT00700622Phase 3Results posted
- Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn PhenomenonCompletedNCT00694122Phase 3Results posted
- Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial InfarctionTerminatedNCT00670228Phase 3Results posted
- Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 DiabetesCompletedNCT00659165Not applicableResults posted
- Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT00612040Phase 2Results posted
- Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General SurgeryCompletedNCT00596687Phase 4Results posted
- Characteristics of Glargine in Type 2 DiabeticsCompletedNCT00574912Phase 1Results posted
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNCT00564018Not applicableResults posted
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and ExenatideCompletedNCT00560417Phase 3Results posted
- Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)TerminatedNCT00500240Phase 3Results posted
- Insulin Secretion in Diabetes Before and After Glycemic ControlCompletedNCT00469833Not applicableResults posted
- A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedNCT00391027Phase 4Results posted